Viewing StudyNCT00203372

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00203372
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2005-09-12
Brief Title: Neoadjuvant TAC Plus or Minus BevacizumabAVF3299
Sponsor: Translational Oncology Research International
Organization: Translational Oncology Research International
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords: